Found 6 matching trials
A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
PHASE1The purpose of this study is to assess the bioequivalence of a new oxycodon...
Location
Covance Clinical Research Unit Madison
To Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
PHASE1The purpose of this study is to assess the bioequivalence of a new oxycodon...
Location
Covance Clinical Research Unit - Evansville
To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
PHASE1The purpose of this study is to assess the bioequivalence of a new oxycodon...
Location
Covance Clinical Research Unit Madison
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
PHASE1To assess the bioequivalence of reformulated OXY tablets (40 mg) relative t...
Location
Covance Clinical Research Unit - Austin
A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
PHASE1The purpose of this study is to assess the bioequivalence of a new oxycodon...
Location
Covance Clinical Research Unit Honolulu
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
PHASE1The purpose of this study is to assess the bioequivalence of a new oxycodon...
Location
Covance Clinical Research Unit